May 29 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Claritev, Rocket Pharmaceuticals and Salesforce, on Thursday.
HIGHLIGHTS
* Claritev Corp CTEV.N: Piper Sandler raises to overweight from neutral |
* Dick's Sporting Goods Inc DKS.N: TD Cowen cuts target price to $205 from $216 |
* Rocket Pharmaceuticals Inc RCKT.O: JP Morgan cuts to neutral from overweight |
* Salesforce Inc CRM.N: Barclays cuts target price to $347 from $425 |
* Veeva Systems Inc VEEV.N: Piper Sandler raises target price to $325 from $255 |
Following is a summary of research actions on U.S. companies reported by Reuters on Thursday. Stock entries are in alphabetical order.
* Abercrombie & Fitch Co ANF.N: Barclays raises target price to $84 from $71 |
* Abercrombie & Fitch Co ANF.N: Citigroup raises target price to $105 from $98 |
* Abercrombie & Fitch Co ANF.N: JP Morgan raises target price to $147 from $142 |
* Abercrombie & Fitch Co ANF.N: Morgan Stanley raises target price to $82 from $78 |
* Abercrombie & Fitch Co ANF.N: Raymond James raises target price to $99 from $90 |
* Aflac Inc AFL.N: Raymond James cuts target price to $110 from $115 |
* Agilent Technologies Inc A.N: JP Morgan cuts target price to $155 from $160 |
* Agilent Technologies Inc A.N: UBS cuts target price to $130 from $150 |
* Air Products APD.N: Morgan Stanley resumes coverage with equal-weight rating; PT $290 |
* Alarum Technologies Ltd ALAR.O: Alliance Global Partners cuts target price to $11 from $13 |
* AMC Entertainment Holdings Inc AMC.N: Citigroup raises target price to $2.60 from $2.30 |
* Aspen Aerogels Inc ASPN.N: Barclays cuts target price to $7 from $13 |
* Aspen Aerogels Inc ASPN.N: Barclays cuts to equal-weight from overweight |
* Axon Enterprise Inc AXON.O: TD Cowen raises target price to $800 from $750 |
* Banzai International Inc BNZI.O: Ascendiant Capital Markets cuts PT to $24 from $26 |
* Booz Allen Hamilton Holding BAH.N: BofA Global Research cuts price objective to $160 from $175 |
* Booz Allen Hamilton Holding BAH.N: JP Morgan cuts target price to $115 from $120 |
* Broadcom Inc AVGO.O: Susquehanna raises target price to $280 from $250 |
* Brown-Forman Corp BFb.N: JP Morgan cuts target price to $34 from $36 |
* Burlington Stores Inc BURL.N: Jefferies cuts target price to $300 from $325 |
* C3.Ai AI.N: BofA Global Research raises price objective to $24 from $22 |
* C3.Ai AI.N: Canaccord Genuity cuts target price to $28 from $30 |
* C3.Ai AI.N: JP Morgan cuts target price to $23 from $27 |
* C3.Ai AI.N: Morgan Stanley raises target price to $22 from $20 |
* C3.Ai AI.N: Oppenheimer cuts target price to $45 from $56 |
* C3.Ai AI.N: UBS raises target price to $28 from $26 |
* Celsius Holdings Inc CELH.O: Deutsche Bank cuts target price to $33 from $35 |
* Celsius Holdings Inc CELH.O: Jefferies raises target price to $45 from $44 |
* Chain Bridge Bancorp Inc CBNA.N: Piper Sandler cuts to neutral from overweight |
* Chipotle Mexican Grill Inc CMG.N: JP Morgan cuts target price to $54 from $58 |
* Claritev Corp CTEV.N: Piper Sandler raises target price to $44 from $19 |
* Claritev Corp CTEV.N: Piper Sandler raises to overweight from neutral |
* Cleveland-Cliffs Inc CLF.N: Jefferies cuts to hold from buy; cuts PT to $6 from $10 |
* Cogent Biosciences Inc COGT.O: JP Morgan raises target price to $25 from $21 |
* Coherent Corp COHR.N: Barclays raises target price to $90 from $80 |
* Coherent Corp COHR.N: BofA Global Research raises price objective to $92 from $80 |
* Coherent Corp COHR.N: Morgan Stanley raises target price to $83 from $74 |
* Coherent Corp COHR.N: Needham raises target price to $90 from $85 |
* Community Health Systems, Inc CYH.N: Wells Fargo raises target price to $3.50 from $2 |
* Conagra Brands Inc CAG.N: Jefferies cuts target price to $23 from $27 |
* Cytokinetics Inc CYTK.O: Mizuho cuts target price to $84 from $103 |
* Darden Restaurants Inc DRI.N: Citigroup raises target price to $245 from $229 |
* Dick's Sporting Goods Inc DKS.N: Barclays raises target price to $232 from $217 |
* Dick's Sporting Goods Inc DKS.N: D.A. Davidson cuts target price to $230 from $273 |
* Dick's Sporting Goods Inc DKS.N: JP Morgan cuts target price to $195 from $224 |
* Dick's Sporting Goods Inc DKS.N: Morgan Stanley cuts target price to $232 from $255 |
* Dick's Sporting Goods Inc DKS.N: TD Cowen cuts target price to $205 from $216 |
* Dick's Sporting Goods Inc DKS.N: Truist Securities cuts target price to $230 from $245 |
* Dick's Sporting Goods Inc DKS.N: UBS cuts target price to $225 from $260 |
* Dollar General Corp DG.N: UBS raises target price to $120 from $95 |
* Dollar Tree Inc DLTR.O: UBS raises target price to $108 from $95 |
* Duolingo Inc DUOL.O: Scotiabank raises target price to $600 from $470 |
* Eagle Point Credit Company Inc ECC.N: KBW cuts target price to $7.50 from $9 |
* Electronic Arts EA.O: Citigroup raises target price to $153 from $139 |
* Elf Beauty Inc ELF.N: BofA Global Research raises target price to $113 from $95 |
* Elf Beauty Inc ELF.N: Canaccord Genuity raises target price to $114 from $105 |
* Elf Beauty Inc ELF.N: Deutsche Bank raises target price to $90 from $80 |
* Elf Beauty Inc ELF.N: Raymond James raises target price to $105 from $95 |
* Elf Beauty Inc ELF.N: TD Cowen raises target price to $130 from $94 |
* Equity Lifestyle Properties ELS.N: Barclays initiates coverage with equal-weight rating and target price $70 |
* Eton Pharmaceuticals Inc ETON.O: H.C. Wainwright raises target price to $35 from $33 |
* Exp World Holdings Inc EXPI.O: D.A. Davidson raises to buy from neutral |
* Fastenal Co FAST.O: Stephens adjusts target price to $40 from $80 to reflect 2-for-1 stock split |
* First Advantage FA.O: Barclays raises target price to $18 from $15 |
* First Citizens Bancshares FCNCA.O: D.A. Davidson cuts target price by $50 to $2,050 |
* GE Aerospace GE.N: Deutsche Bank raises target price to $300 from $261 |
* GM GM.N: Citigroup cuts target price to $59 from $62 |
* Hasbro Inc HAS.O: Morgan Stanley raises target price to $77 from $71 |
* HEICO Corp HEI.N: RBC raises target price to $315 from $285 |
* HEICO Corp HEI.N: UBS raises target price to $306 from $264 |
* HP Inc HPQ.N: Barclays cuts target price to $28 from $36 |
* HP Inc HPQ.N: BofA Global Research cuts price objective to $29 from $33 |
* HP Inc HPQ.N: Citigroup cuts target price to $27.50 from $29 |
* HP Inc HPQ.N: JP Morgan cuts target price to $27 from $30 |
* HP Inc HPQ.N: Morgan Stanley cuts target price to $26 from $29 |
* HP Inc HPQ.N: TD Cowen cuts target price to $28 from $38 |
* HP Inc HPQ.N: UBS cuts target price to $26 from $37 |
* HP Inc HPQ.N: Wells Fargo cuts target price to $25 from $35 |
* Intellia Therapeutics NTLA.O: BofA Global Research cuts price objective to $39 from $43 |
* Intellia Therapeutics Inc NTLA.O: Wedbush cuts target price to $7 from $10 |
* Iteos Therapeutics Inc ITOS.O: Wells Fargo cuts target price to $12 from $13 |
* JLL JLL.N: Jefferies cuts target price to $264 from $266 |
* Kellanova K.N: Citigroup resumes coverage with neutral rating; target price $83.50 |
* Lineage Inc LINE.O: Mizuho cuts target price to $51 from $67 |
* Lionsgate Studios Corp LION.O: Citigroup cuts target price to $10 from $13 |
* Lipocine Inc LPCN.O: H.C. Wainwright assumes coverage with buy rating; PT $8 |
* Macy's Inc M.N: Citigroup raises target price to $12 from $11 |
* Macy's Inc M.N: Jefferies cuts target price to $14.50 from $17 |
* Mastec Inc MTZ.N: Jefferies raises target price to $193 from $188 |
* Monro Inc MNRO.O: Jefferies cuts target price to $18 from $22 |
* Monro Inc MNRO.O: Stephens raises target price to $20 from $18 |
* Monro Inc MNRO.O: Wells Fargo raises target price to $16 from $15 |
* Ncino Inc NCNO.O: Barclays raises target price to $31 from $24 |
* Ncino Inc NCNO.O: BofA Global Research raises price objective to $30 from $28 |
* Ncino Inc NCNO.O: KBW raises target price to $33 from $28 |
* Ncino Inc NCNO.O: Morgan Stanley raises target price to $29 from $27 |
* Ncino Inc NCNO.O: Piper Sandler raises target price to $28 from $25 |
* Ncino Inc NCNO.O: Truist Securities raises target price to $27 from $21 |
* Netflix Inc NFLX.O: Citigroup raises target price to $1,250 from $1,020 |
* Netstreit Corp NTST.N: Jefferies raises target price to $18 from $17 |
* Nexpoint Residential Trust Inc NXRT.N: Truist Securities cuts PT to $38 from $42 |
* Nlight Inc LASR.O: Needham raises target price to $18 from $14 |
* Nucor Corp NUE.N: UBS cuts target price to $147 from $153 |
* Nuscale Power Corp SMR.N: UBS raises target price to $34 from $17 |
* Nutanix Inc NTNX.O: Susquehanna raises target price to $95 from $90 |
* NVIDIA Corp NVDA.O: Barclays raises target price to $170 from $155 |
* NVIDIA Corp NVDA.O: BofA Global Research raises price objective to $180 from $160 |
* NVIDIA Corp NVDA.O: Citigroup raises target price to $180 from $150 |
* NVIDIA Corp NVDA.O: D.A. Davidson raises target price to $135 from $120 |
* NVIDIA Corp NVDA.O: Deutsche Bank raises target price to $145 from $125 |
* NVIDIA Corp NVDA.O: Mizuho raises target price to $170 from $168 |
* NVIDIA Corp NVDA.O: Morgan Stanley raises target price to $170 from $160 |
* NVIDIA Corp NVDA.O: Piper Sandler raises target price to $180 from $150 |
* NVIDIA Corp NVDA.O: TD Cowen raises target price to $175 from $140 |
* NVIDIA Corp NVDA.O: Truist Securities raises target price to $210 from $205 |
* Outfront Media Inc OUT.N: Citigroup raises target price to $19 from $17 |
* Paramount Global PARA.O: Citigroup cuts to neutral from buy; cuts PT to $12 from $13 |
* Pepgen Inc PEPG.O: H.C. Wainwright cuts target price to $8 from $14 |
* Performance Food Group Co PFGC.N: Barclays raises target price to $112 from $100 |
* Performance Food Group Co PFGC.N: Morgan Stanley raises target price to $93 from $92 |
* Performance Food Group Co PFGC.N: UBS raises target price to $110 from $103 |
* Pfizer PFE.N: Berenberg cuts target price to $25 from $28 |
* Phreesia Inc PHR.N: Citigroup cuts target price to $33 from $35 |
* Phreesia Inc PHR.N: Truist Securities raises target price to $35 from $34 |
* Popular Inc BPOP.O: Wells Fargo raises target price to $130 from $110 |
* Pure Storage Inc PSTG.N: Barclays cuts target price to $57 from $61 |
* Pure Storage Inc PSTG.N: BofA Global Research raises price objective to $76 from $73 |
* Pure Storage Inc PSTG.N: JP Morgan cuts target price to $70 from $75 |
* Pursuit Attractions and Hospitality PRSU.N: Stifel initiates coverage with buy rating |
* Pursuit Attractions and Hospitality PRSU.N: Stifel initiates coverage with target price $38 |
* Realty Income Corp O.N: Jefferies raises target price to $62 from $60 |
* Rhythm Pharmaceuticals Inc RYTM.O: Stifel raises target price to $94 from $78 |
* Roblox Corp RBLX.N: Citigroup raises target price to $100 from $85 |
* Rocket Companies Inc RKT.N: UBS raises target price to $14 from $13 |
* Rocket Pharmaceuticals Inc RCKT.O: JP Morgan cuts target price to $7 from $44 |
* Rocket Pharmaceuticals Inc RCKT.O: JP Morgan cuts to neutral from overweight |
* Rubrik Inc RBRK.N: CIBC raises target price to $110 from $85 |
* Ryman Hospitality Properties Inc RHP.N: Jefferies raises PT to $115 from $109 |
* Salesforce Inc CRM.N: Baird cuts target price to $365 from $400 |
* Salesforce Inc CRM.N: Barclays cuts target price to $347 from $425 |
* Salesforce Inc CRM.N: Barclays cuts target price to $347 from $425 |
* Salesforce Inc CRM.N: Bernstein raises target price to $255 from $243 |
* Salesforce Inc CRM.N: D.A. Davidson raises target price to $225 from $200 |
* Salesforce Inc CRM.N: Morgan Stanley raises target price to $404 from $393 |
* Salesforce Inc CRM.N: Northland Capital cuts target price to $396 from $423 |
* Salesforce Inc CRM.N: Oppenheimer cuts target price to $370 from $380 |
* Salesforce Inc CRM.N: Piper Sandler raises target price to $335 from $315 |
* Salesforce Inc CRM.N: RBC cuts target price to $275 from $420 |
* Salesforce Inc CRM.N: RBC cuts to sector perform from outperform |
* Salesforce Inc CRM.N: Wells Fargo raises target price to $275 from $255 |
* Savara Inc SVRA.O: H.C. Wainwright cuts target price to $2 from $6 |
* Sentinelone Inc S.N: Barclays cuts target price to $19 from $21 |
* Sentinelone Inc S.N: Bernstein cuts target price to $25 from $27 |
* Sentinelone Inc S.N: BofA Global Research cuts price objective to $21 from $24 |
* Sentinelone Inc S.N: BofA Global Research cuts to neutral from buy |
* Sentinelone Inc S.N: BTIG cuts target price to $21 from $27 |
* Sentinelone Inc S.N: D.A. Davidson cuts target price to $17 from $18 |
* Sentinelone Inc S.N: Deutsche Bank cuts target price to $22 from $28 |
* Sentinelone Inc S.N: JP Morgan cuts target price to $19 from $22 |
* Sentinelone Inc S.N: JP Morgan cuts to neutral from overweight |
* Sentinelone Inc S.N: Scotiabank cuts target price to $18 from $19 |
* Sentinelone Inc S.N: Susquehanna cuts target price to $24 from $25 |
* Sentinelone Inc S.N: UBS cuts target price to $19 from $21 |
* Sentinelone Inc S.N: Wedbush cuts target price to $23 from $25 |
* Sentinelone Inc S.N: Wells Fargo cuts target price to $18 from $22 |
* Skyward Specialty Insurance Group SKWD.O: KBW raises target price to $72 from $67 |
* Sono-Tek Corp SOTK.O: Northland Capital cuts to market perform from outperform |
* Southwest Airlines Co LUV.N: Deutsche Bank raises target price to $40 from $28 |
* Southwest Airlines Co LUV.N: Deutsche Bank raises to buy from hold |
* Starbucks SBUX.O: TD Cowen cuts to hold from buy |
* Sun Communities SUI.N: Barclays initiates coverage with overweight rating and PT $141 |
* Superior Group of Companies Inc SGC.O: Noble Capital initiates coverage with $16 price target |
* Superior Group of Companies Inc SGC.O: Noble Capital initiates coverage with outperform rating |
* Synopsys Inc SNPS.O: BofA Global Research raises price objective to $575 from $560 |
* Tenet Healthcare Corporation THC.N: Wells Fargo raises target price to $195 from $150 |
* Transdigm Group Inc TDG.N: BofA Global Research raises price objective to $1,615 from $1,500 |
* Tripadvisor Inc TRIP.O: Citigroup resumes coverage with neutral rating; PT $16 |
* Vail Resorts Inc MTN.N: Deutsche Bank cuts target price to $171 from $183 |
* Veeva Systems Inc VEEV.N: Barclays raises target price to $300 from $285 |
* Veeva Systems Inc VEEV.N: BofA Global Research raises price objective to $304 from $254 |
* Veeva Systems Inc VEEV.N: BTIG raises target price to $335 from $280 |
* Veeva Systems Inc VEEV.N: Morgan Stanley raises target price to $210 from $201 |
* Veeva Systems Inc VEEV.N: Needham raises target price to $300 from $270 |
* Veeva Systems Inc VEEV.N: Piper Sandler raises target price to $325 from $255 |
* Veeva Systems Inc VEEV.N: Raymond James raises target price to $310 from $285 |
* Veeva Systems Inc VEEV.N: RBC raises target price to $330 from $285 |
* Veeva Systems Inc VEEV.N: Scotiabank raises target price to $270 from $245 |
* Veeva Systems Inc VEEV.N: Stifel raises target price to $295 from $272 |
* Veeva Systems Inc VEEV.N: TD Cowen raises target price to $284 from $261 |
* Veeva Systems Inc VEEV.N: Truist Securities raises target price to $230 from $217 |
* Veeva Systems Inc VEEV.N: UBS raises target price to $285 from $250 |
* Veeva Systems Inc VEEV.N: Wells Fargo raises target price to $300 from $285 |
* Warner Bros Discovery Inc WBD.O: Citigroup cuts target price to $14 from $15 |
* Warner Music Group Corp WMG.O: Citigroup cuts target price to $34 from $35 |
* Western Midstream Partners LP WES.N: RBC cuts target price to $38 from $39 |
* Wideopenwest Inc WOW.N: Benchmark cuts target price to $6.50 from $7.50 |
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.